Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nuclear Magnetic Resonance Imaging Study of Treatment With Sertraline in Geriatric Depression.

Trial Profile

Nuclear Magnetic Resonance Imaging Study of Treatment With Sertraline in Geriatric Depression.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Sertraline (Primary)
  • Indications Major depressive disorder
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 02 Mar 2010 Actual end date (Aug 2008), actual initiation date (Nov 2004) and actual number of patients (43) added as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Additional lead trial centres and investigators identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top